{"uri":"collection-of-protocols-accompanying-bispecific-t-ib8carw","version_id":"0","protocol_name":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","protocol_name_html":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"0","last_modified":"1522216802","type_id":"3","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":"","public_fork_note":"","number_of_steps":"10","has_versions":"0","first_published_date":"1496862376","publish_date":"2017-06-07 19:06:16","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"6240","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1496786775","protocol_affiliation":"","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.ib8carw","doi_status":"2","changed_fork_steps":null,"profile_url":"x2y284w2t2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/006.png","full_name":"Sandra Ross","created_by":"Sandra Ross","private_link":"3C3D3DCB0CB2D3AE7A9250F178701209","original_img":"1","username":"sandra-ross","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0183390","manuscript_citation":"Ross SL,  Sherman M,  McElroy PL,  Lofgren JA,  Moody G,  Baeuerle PA,  Coxon A,  Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE  12(8). doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0183390\">10.1371\/journal.pone.0183390<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":243364,"fork_info":[],"compare_forks":[],"protocols":[{"protocol_name":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_name_html":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_id":"5799","version_id":"0","last_modified":"1522217461","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"5","vendor_id":"1","downloads":"0","views":"95","uri":"bite-bystander-t-cell-dependent-cellular-cytotoxic-hwfb7bn","description":"<p>Protocol for detecting bystander cytotoxicity in mixed cultures of target-negative and target-positive cells treated with BiTE\u00ae antibody constructs. Two methods and one modification are described.<\/p>","public":"1","created_on":"1494373710","first_published_date":"2017-05-17 19:40:15","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hwfb7bn","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5799","protocol_name":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_name_html":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"bite-bystander-t-cell-dependent-cellular-cytotoxic-hwfb7bn","version_id":"0","date_created":"2017-05-09 23:48:30","created_on":"1494373710","published_on":"1495050015","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"},{"protocol_id":"5978","protocol_name":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_name_html":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"25514","uri":"bite-bystander-t-cell-dependent-cellular-cytotoxic-h32b8qe","version_id":"1","date_created":"2017-05-17 20:05:32","created_on":"1495051532","published_on":null,"full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_name_html":"BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_id":"5798","version_id":"0","last_modified":"1521698401","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"9","vendor_id":"1","downloads":"0","views":"240","uri":"bite-t-cell-dependent-cellular-cytotoxicity-tdcc-a-hweb7be","description":"<p>T cell dependent cytotoxicity assay for measuring bispecific T cell engager (BiTE<strong>\u00ae)<\/strong> activity.<\/p>","public":"1","created_on":"1494370479","first_published_date":"2017-05-17 19:41:52","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hweb7be","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5798","protocol_name":"BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_name_html":"BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"bite-t-cell-dependent-cellular-cytotoxicity-tdcc-a-hweb7be","version_id":"0","date_created":"2017-05-09 22:54:39","created_on":"1494370479","published_on":"1495050112","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"1"}},{"protocol_name":"BiTE\u00ae Xenograft Protocol","protocol_name_html":"BiTE\u00ae Xenograft Protocol","protocol_id":"6022","version_id":"0","last_modified":"1522044002","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"6","vendor_id":"1","downloads":"0","views":"89","uri":"bite-xenograft-protocol-h5eb83e","description":"<p>This protocol describes methods for a mouse xenograft study designed to measure in vivo BiTE\u00ae\u00a0efficacy against antigen-expressing human tumor cells. In a modified version, the protocol is used to measure BiTE\u00ae-mediated bystander killing. Mixtures of human EGFR-positive (unlabeled) and EGFR-negative (luciferase-labeled) cells are implanted in nude mice along with human T cells. Mice are treated daily with BiTE\u00ae, beginning one\u00a0day after tumor implant\u00a0for 20 days. Growth of EGFR-negative cells is measured by imaging (luminescence) and by calipers (tumor volume).<\/p>","public":"1","created_on":"1495474978","first_published_date":"2017-05-22 18:22:36","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.h5eb83e","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"6022","protocol_name":"BiTE\u00ae Xenograft Protocol","protocol_name_html":"BiTE\u00ae Xenograft Protocol","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"bite-xenograft-protocol-h5eb83e","version_id":"0","date_created":"2017-05-22 17:42:58","created_on":"1495474978","published_on":"1495477356","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"1"}},{"protocol_name":"Bystander Receptor Blockade:  IFN\u03bbR1, TNFRSF1A, ICAM-1 and FAS","protocol_name_html":"Bystander Receptor Blockade:  IFN\u03bbR1, TNFRSF1A, ICAM-1 and FAS","protocol_id":"5824","version_id":"0","last_modified":"1517724003","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"7","vendor_id":"1","downloads":"0","views":"10","uri":"bystander-receptor-blockade-ifn-r1-tnfrsf1a-icam-1-hw8b7hw","description":"<p>This protocol describes the use of neutralizing antibodies to block receptrs for assessing involvement in bystander killing by\u00a0BiTE\u00ae-activated T cells.<\/p>","public":"1","created_on":"1494456282","first_published_date":"2017-05-17 19:41:20","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hw8b7hw","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5824","protocol_name":"Bystander Receptor Blockade:  IFN\u03bbR1, TNFRSF1A, ICAM-1 and FAS","protocol_name_html":"Bystander Receptor Blockade:  IFN\u03bbR1, TNFRSF1A, ICAM-1 and FAS","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"bystander-receptor-blockade-ifn-r1-tnfrsf1a-icam-1-hw8b7hw","version_id":"0","date_created":"2017-05-10 22:44:42","created_on":"1494456282","published_on":"1495050080","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"Human FASL ELISA assay","protocol_name_html":"Human FASL ELISA assay","protocol_id":"5818","version_id":"0","last_modified":"1517724003","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"16","vendor_id":"1","downloads":"0","views":"16","uri":"human-fasl-elisa-assay-hw2b7ge","description":"<p>This protocol describes an ELISA\u00a0assay \u00a0for measurement of FAS ligand (FASL, CD95L)\u00a0in\u00a0supernatants collected from T cell dependent cytotoxicity (TDCC) cultures after BiTE\u00ae treatment.<\/p>","public":"1","created_on":"1494437489","first_published_date":"2017-05-17 19:42:03","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hw2b7ge","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5818","protocol_name":"Human FASL ELISA assay","protocol_name_html":"Human FASL ELISA assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"human-fasl-elisa-assay-hw2b7ge","version_id":"0","date_created":"2017-05-10 17:31:29","created_on":"1494437489","published_on":"1495050123","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"Human Granzyme B (CTLA-1) ELISA assay","protocol_name_html":"Human Granzyme B (CTLA-1) ELISA assay","protocol_id":"5821","version_id":"0","last_modified":"1517724003","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"15","vendor_id":"1","downloads":"0","views":"16","uri":"human-granzyme-b-ctla-1-elisa-assay-hw5b7g6","description":"<p>This protocol describes an ELISA assay \u00a0for measurement of Granzyme B (CTLA-1)\u00a0in\u00a0supernatants collected from T cell dependent cytotoxicity (TDCC) cultures after BiTE\u00ae treatment.<\/p>","public":"1","created_on":"1494439438","first_published_date":"2017-05-17 19:42:23","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hw5b7g6","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5821","protocol_name":"Human Granzyme B (CTLA-1) ELISA assay","protocol_name_html":"Human Granzyme B (CTLA-1) ELISA assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"human-granzyme-b-ctla-1-elisa-assay-hw5b7g6","version_id":"0","date_created":"2017-05-10 18:03:58","created_on":"1494439438","published_on":"1495050143","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"Immunofluorescence:  EGFR, ICAM-1 and FAS detection","protocol_name_html":"Immunofluorescence:  EGFR, ICAM-1 and FAS detection","protocol_id":"5800","version_id":"0","last_modified":"1520920802","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"4","vendor_id":"1","downloads":"0","views":"45","uri":"immunofluorescence-egfr-icam-1-and-fas-detection-hwgb7bw","description":"<p>This protocol describes methods for detecting cell-surface markers by indirect immunofluorescence after treatment with BiTE\u00ae. Cells are analyzed by cellular imaging.<\/p>","public":"1","created_on":"1494374680","first_published_date":"2017-05-17 19:42:32","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hwgb7bw","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5800","protocol_name":"Immunofluorescence:  EGFR, ICAM-1 and FAS detection","protocol_name_html":"Immunofluorescence:  EGFR, ICAM-1 and FAS detection","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"immunofluorescence-egfr-icam-1-and-fas-detection-hwgb7bw","version_id":"0","date_created":"2017-05-10 00:04:40","created_on":"1494374680","published_on":"1495050152","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"MSD 96-well human cytokine assay","protocol_name_html":"MSD 96-well human cytokine assay","protocol_id":"5817","version_id":"0","last_modified":"1521525601","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"12","vendor_id":"1","downloads":"0","views":"41","uri":"msd-96-well-human-cytokine-assay-hwzb7f6","description":"<p>This protocol describes MesoScale Discovery (MSD) assays \u00a0for measurement of proinflammatory cytokines in\u00a0supernatants collected from T cell dependent cytotoxicity (TDCC) cultures after BiTE\u00ae treatment.<\/p>","public":"1","created_on":"1494435652","first_published_date":"2017-05-17 19:42:41","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hwzb7f6","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5817","protocol_name":"MSD 96-well human cytokine assay","protocol_name_html":"MSD 96-well human cytokine assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"msd-96-well-human-cytokine-assay-hwzb7f6","version_id":"0","date_created":"2017-05-10 17:00:52","created_on":"1494435652","published_on":"1495050161","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"Supernatant Transfer Assay  and Transwell\u00ae Assay","protocol_name_html":"Supernatant Transfer Assay  and Transwell\u00ae Assay","protocol_id":"5973","version_id":"0","last_modified":"1522216802","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"4","vendor_id":"1","downloads":"0","views":"95","uri":"supernatant-transfer-assay-and-transwell-assay-h3vb8n6","description":"<p>This protocol describes two methods for assessing whether soluble factors alone or a combination of soluble factors and T cells are responsible for bystander killing: (1) Supernatant transfer assays and (2)\u00a0Transwell\u00ae assays.<\/p>","public":"1","created_on":"1494981407","first_published_date":"2017-05-17 19:42:50","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.h3vb8n6","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5973","protocol_name":"Supernatant Transfer Assay  and Transwell\u00ae Assay","protocol_name_html":"Supernatant Transfer Assay  and Transwell\u00ae Assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"supernatant-transfer-assay-and-transwell-assay-h3vb8n6","version_id":"0","date_created":"2017-05-17 00:36:47","created_on":"1494981407","published_on":"1495050170","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"T cell activation assay","protocol_name_html":"T cell activation assay","protocol_id":"5801","version_id":"0","last_modified":"1522216802","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":null,"number_of_steps":"4","vendor_id":"1","downloads":"0","views":"470","uri":"t-cell-activation-assay-hwhb7b6","description":"<p>This protocol describes a method for detecting T cell activation in response to BiTE<strong>\u00ae<\/strong> treatment by flow cytometry .<\/p>","public":"1","created_on":"1494375319","first_published_date":"2017-05-17 19:43:01","authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","has_guidelines":"0","has_warning":"0","has_before_start":"0","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","doi":"dx.doi.org\/10.17504\/protocols.io.hwhb7b6","doi_status":"2","type_id":"1","created_by":"Sandra Ross","is_bookmarked":"0","affiliation":null,"username":"sandra-ross","first_name":"Sandra","last_name":"Ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","groups":[],"versions":[{"protocol_id":"5801","protocol_name":"T cell activation assay","protocol_name_html":"T cell activation assay","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","user_id":"0","uri":"t-cell-activation-assay-hwhb7b6","version_id":"0","date_created":"2017-05-10 00:15:19","created_on":"1494375319","published_on":"1495050181","full_name":"Sandra Ross","username":"sandra-ross","affiliation":null,"profile_image":"\/img\/avatars\/006.png","has_access":"1"}],"forks_count":{"public":"0","private":"0"}}],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"1","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"4","badge_image":"\/img\/badges\/gold.svg","badge_description":"Gold power author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"","authors_list":[],"user":{"profile_image":"\/img\/avatars\/006.png","username":"sandra-ross","full_name":"Sandra Ross","created_by":"Sandra Ross"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":null,"steps":[]}